Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Shin BH et al. |
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. |
2014 |
Transplantation |
pmid:24342979
|
First MR and Fitzsimmons WE |
New drugs to improve transplant outcomes. |
2004 |
Transplantation |
pmid:15201693
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Yoon SH et al. |
CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). |
2013 |
Transplantation |
pmid:23364483
|
Jain AB et al. |
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. |
2004 |
Transplantation |
pmid:15077034
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Ravindran VK et al. |
Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. |
2009 |
Transplantation |
pmid:19543067
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Jindal RM et al. |
Effect of deoxyspergualin on the endocrine function of the rat pancreas. |
1993 |
Transplantation |
pmid:7504347
|
Millis JM et al. |
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. |
1996 |
Transplantation |
pmid:8629298
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Butani L et al. |
Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. |
2003 |
Transplantation |
pmid:12883183
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation. |
2017 |
Transplantation |
pmid:27482958
|
Marcén R et al. |
Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. |
2006 |
Transplantation |
pmid:16570003
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. |
2006 |
Transplantation |
pmid:16570006
|
Reddy KS et al. |
Simultaneous kidney-pancreas transplantation without antilymphocyte induction. |
2000 |
Transplantation |
pmid:10653379
|
Sood P et al. |
Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. |
2012 |
Transplantation |
pmid:23018881
|
Galliford J et al. |
ABO incompatible living renal transplantation with a steroid sparing protocol. |
2008 |
Transplantation |
pmid:18852653
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Naesens M and Sarwal MM |
Monitoring calcineurin inhibitor therapy: localizing the moving target. |
2010 |
Transplantation |
pmid:20458272
|
Watson MJ et al. |
Renal function impacts outcomes after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622288
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
Amundsen R et al. |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. |
2009 |
Transplantation |
pmid:19384170
|
Jun KR et al. |
Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. |
2009 |
Transplantation |
pmid:19384171
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Ji E et al. |
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. |
2012 |
Transplantation |
pmid:22992768
|
Radkowski M et al. |
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9753352
|
Egashira K et al. |
Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. |
2003 |
Transplantation |
pmid:12698101
|
Egli A et al. |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. |
2013 |
Transplantation |
pmid:23274966
|
Hu H et al. |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. |
2003 |
Transplantation |
pmid:12698107
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Fujishiro J et al. |
Immunologic benefits of longer graft in rat allogenic small bowel transplantation. |
2005 |
Transplantation |
pmid:15665767
|
Thai NL et al. |
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. |
2006 |
Transplantation |
pmid:17198247
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Hewitt CW and Black KS |
Comparative studies of FK506 with cyclosporine. |
1988 |
Transplantation |
pmid:2458644
|
Aisa Y et al. |
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. |
2005 |
Transplantation |
pmid:16278584
|
Rezeig MA et al. |
Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. |
1997 |
Transplantation |
pmid:9175820
|
Tanaka J et al. |
The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells. |
2005 |
Transplantation |
pmid:16378079
|
Dharancy S et al. |
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. |
2007 |
Transplantation |
pmid:17460561
|
Vadivel N et al. |
Tacrolimus dose in black renal transplant recipients. |
2007 |
Transplantation |
pmid:17460575
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|